July 13, 2017
Via: medicaldevice-network.comFrench firm Defymed has developed a new insulin delivery device ExOlin to facilitate better disease management for both type 1 and type 2 diabetes patients. ExOlin consists of a biocompatible membrane that is non-biodegradable and permeable to insulin. The device […]
March 28, 2024
April 19, 2024